Cooperative AgreementPostedDiscretionary

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats

National Institutes of Health
RFA-AI-27-014
Application Deadline
Days Remaining
Until deadline
Award Ceiling
Total Program Funding

Grant Opportunity Analysis

The National Institute of Allergy and Infectious Diseases, on behalf of NIH, is seeking cooperative agreement support to advance research on candidate medical countermeasures and enabling technologies for chemical or radiation/nuclear threats. The work focuses on developing radiation-focused models, biomarkers of damage, devices to assess and predict injury, and products that can improve survival and reduce morbidity, along with preclinical products to mitigate and treat injuries from government-designated chemicals of concern. The effort is aimed at post-exposure candidates for civilian mass-casualty settings and is administered through NIAID’s Radiation and Nuclear and Chemical Countermeasures Research Programs, with no cost sharing required. The estimated synopsis post date is July 10, 2026, the estimated close date is October 9, 2026, and the estimated award and project start date is July 1, 2027.

Eligible Applicants

Others
Additional Eligibility Information

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations.

Grant Documents

0 Files
No documents available for this grant.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedApr 9, 2026

Funding Details

No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Cooperative Agreement

Grantor Contact

Name
National Institute of Allergy and Infectious Diseases (NIAID)

CFDA Numbers

93.867

Official Sources